Tim Niklas Bewersdorf

Dr. Tim Niklas Bewersdorf

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
JHJakob Hofmann
Jakob Hofmann
TBTim Niklas Bewersdorf
Tim Niklas Bewersdorf
USUlrike Sommer
Ulrike Sommer
TLThomas Lingner
Thomas Lingner
SFSebastian Findeisen
Sebastian Findeisen
TGTobias Grossner
Tobias Grossner
Antibiotic-loaded PMMA bone cement is frequently used in modern trauma and orthopedic surgery. Although many of the antibiotics routinely applied are described to have cytotoxic effects in the literature, clinical experience shows no adverse effects for bone healing. To determine the effects of antibiotic-loaded PMMA spacers on osteogenesis in vitro, we cultivated human bone marrow mesenchymal stem cells (BM-hMSCs) in the presence of PMMA spacers containing Gentamicin, Vancomycin, Gentamicin + Clindamycin as well as Gentamicin + Vancomycin in addition to a blank control (agarose) and PMMA containing no antibiotics. The cell number was assessed with DAPI staining, and the osteogenic potential was evaluated by directly measuring the amount of hydroxyapatite synthesized using radioactive 99mTc-HDP labelling as well as measuring the concentration of calcium and phosphate in the cell culture medium supernatant. The results showed that Gentamicin and Vancomycin as well as their combination show a certain amount of cytotoxicity but no negative effect on osteogenic potential. The combination of Gentamicin and Clindamycin, on the other hand, led to a drastic reduction in both the cell count and the osteogenic potential.

Verified
Journal Article
Open access
PDF file
JHJakob Hofmann
Jakob Hofmann
KBKai Borcherding
Kai Borcherding
KTKarsten Thiel
Karsten Thiel
TLThomas Lingner
Thomas Lingner
USUlrike Sommer
Ulrike Sommer
TGTobias Grossner
Tobias Grossner
99-Metastabil Technetium (99mTc) is a radiopharmaceutical widely used in skeletal scintigraphy. Recent publications show it can also be used to determine the osteogenic potential of human mesenchymal stem cells (hMSCs) by binding to hydroxyapatite formed during bone tissue engineering. This field lacks non-destructive methods to track live osteogenic differentiation of hMSCs. However, no data about the uptake kinetics of 99mTc and its effect on osteogenesis of hMSCs have been published yet. We therefore evaluated the saturation time of 99mTc by incubating hMSC cultures for different periods, and the saturation concentration by using different amounts of 99mTc activity for incubation. The influence of 99mTc on osteogenic potential of hMSCs was then evaluated by labeling a continuous hMSC culture three times over the course of 3 weeks, and comparing the findings to cultures labeled once. Our findings show that 99mTc saturation time is less than 0.25 h, and saturation concentration is between 750 and 1000 MBq. Repeated exposure to γ-radiation emitted by 99mTc had no negative effects on hMSC cultures. These new insights can be used to make this highly promising method broadly available to support researchers in the field of bone tissue engineering using this method to track and evaluate, in real-time, the osteogenic differentiation of hMSC, without any negative influence on the cell viability, or their osteogenic differentiation potential.

6 January 2025 in Bone & Joint Open
Verified
Journal Article
Open access
PDF file
SFSebastian Findeisen
Sebastian Findeisen
LMLouis Mennerat
Louis Mennerat
TFThomas Ferbert
Thomas Ferbert
LHLars Helbig
Lars Helbig
TBTim Niklas Bewersdorf
Tim Niklas Bewersdorf
MTMichael Tanner
Michael Tanner
Aims: The aim of this study was to evaluate the radiological outcome of patients with large bone defects in the femur and tibia who were treated according to the guidelines of the diamond concept in our department (Centre for Orthopedics, Trauma Surgery, and Paraplegiology).Methods: The following retrospective, descriptive analysis consists of patients treated in our department between January 2010 and December 2021. In total, 628 patients were registered, of whom 108 presented with a large-sized defect (≥ 5 cm). A total of 70 patients met the inclusion criteria. The primary endpoint was radiological consolidation of nonunions after one and two years via a modified Lane-Sandhu Score, including only radiological parameters.Results: The mean defect size was 6.77 cm (SD 1.86), with the largest defect being 12.6 cm. Within two years after surgical treatment, 45 patients (64.3%) presented consolidation of the previous nonunion. After one year, six patients (8.6%) showed complete consolidation and 23 patients (32.9%) showed a considerable callus formation, whereas 41 patients (58.6%) showed a Lane-Sandhu score of 2 or below. Two years after surgery, 24 patients (34.3%) were categorized as Lane-Sandhu score 4, another 23 patients (32.9%) reached a score of 3, while 14 patients (20.0%) remained without final consolidation (score ≤ 2). A total of nine patients (12.9%) missed the two-year follow-up. The mean follow-up was 44.40 months (SD 32.00). The mean time period from nonunion surgery to consolidation was 16.42 months (SD 9.73)Conclusion: Patients with presentation of a large-sized nonunion require a structured and sufficiently long follow-up to secure the consolidation of the former nonunion. Furthermore, a follow-up of at least two years is required in order to declare a nonunion as consolidated, given that a significant part of the nonunions declared as not consolidated at one year showed consolidation within the second year. Moreover, the proven “gold standard” of a two-step procedure, so called Masquelet technique, shows effectiveness.Cite this article: Bone Jt Open 2024;6(1):26–34.

29 March 2026 in Journal of Epidemiology and Global Health
Verified
Journal Article
Open access
PDF file
NGNiklas Graefe
Niklas Graefe
LMLudwig Matrisch
Ludwig Matrisch
SFSebastian Findeisen
Sebastian Findeisen
TGTobias Grossner
Tobias Grossner
JSJan Streblow
Jan Streblow
TBTim Niklas Bewersdorf
Tim Niklas Bewersdorf
Background: Non-unions (NU) after fractures, especially in cases with the need of surgical intervention, represent one of the most severe complications in traumatology. As previous studies estimate post-fracture NU risk between 2% and 10% data inconsistencies persist. In particular, the data on the influence of different anatomical regions, age and sex on fracture associated NU is scarce. Therefore, this study aims to provide a comprehensive descriptively assessment of the ratio of surgically treated tibia and femur NU to tibia and femur fractures based on a nationwide dataset, with a specific focus on differences across anatomical regions. Methods: This retrospective, population-based, cross-sectional analysis of the German InEK database (2019–2023) was conducted, including 888,442 fractures and 3,017 NU cases. The study focused on ICD- (International Statistical Classification of Diseases and Related Health Problems-) coded diagnoses of femur and tibia NU and their associated fractures. To enhance precision, fracture and NU sites were grouped according to different anatomical regions assessed by documented OPS- (Operation and Procedure Classification System) codes. Subgroup analyses were performed for age and sex. Results: Surgically treated femoral shaft NU had the highest incidence (0.18 cases per 100,000 residents and year), followed closely by tibial shaft NU (0.16). The highest NU/100-fractures ratio was observed in tibial shaft (1.277), followed by distal tibia (1.095) and distal femur (0.996). Across all localisations, men had clearly higher NU/100-fractures ratios than women. NU/100-fractures ratios also varied with age, with highest ratio in the economically active population, followed by a generally decline in older patients. Conclusion: This nationwide database study indicates that surgically treated NU/fracture ratios of femur and tibia are generally low. The proportion of NU to fracture differ between different anatomical regions. In general, proximal localisations showed lower NU/100-fractures ratios than distal localisations within the femur and in comparison of femur and tibia. Independently of the anatomical localisation men had a higher NU/100-fractures ratio than women. As highest NU/100-fractures ratios were detected in the economically active population, this highlights the substantial socioeconomic burden associated with this condition.

16 February 2026 in European Journal of Trauma and Emergency Surgery
Verified
Journal Article
Open access
PDF file
TBTim Niklas Bewersdorf
Tim Niklas Bewersdorf
JHJakob Hofmann
Jakob Hofmann
LBLaura Boehm
Laura Boehm
SFSebastian Findeisen
Sebastian Findeisen
CSChristian Schamberger
Christian Schamberger
TGTobias Grossner
Tobias Grossner
Purpose: This study compares the proliferative and osteogenic activity of human bone marrow derived mesenchymal stem cells (MSCs) obtained from atrophic non-unions and from healthy autologous bone graft tissue (harvested from iliac crest or femoral canal) of the same patient in an in-vitro setting utilizing a matched control study design. Methods: MSCs underwent osteogenic differentiation over 3 weeks in-vitro ( n = 6 donors; n = 36 samples/group) and the proliferative activity was accessed using DAPI-based immunofluorescence microscopy and WST-1 assay. All results regarding the osteogenic activity were normalized to 10 4 cells to eliminate a proliferation bias. The late osteogenic activity was evaluated by radioactive 99m Technetium-hydroxydiphosphonate labelling of depleted hydroxyapatite, while early osteogenic markers (calcium concentration and alkaline phosphatase activity) were analysed in supernatants of cell culture media. Results: The early and late-stage osteogenic activity of atrophic non-union MSCs was significantly higher compared to healthy control graft MSCs on day 21 of osteogenic differentiation in-vitro, both in absolute numbers (early/late: p < 0.001) and after normalization to 10 4 cells (early/late: p < 0.001). After lower proliferative activity during the first week, non-union MSC regained good proliferative activity during the second week resulting in comparable absolute cell counts to healthy control graft MSCs after three weeks. Conclusion: The results emphasize that the in-vitro osteogenic and proliferative activity of atrophic non-union MSCs is not impaired as clinically assumed but the osteogenic potential of atrophic non-union MSCs is in fact significantly higher compared to graft derived MSCs. This might be an important basic-science insight for the optimization of clinical non-union therapies.

30 May 2026 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
JBJessica C. Böpple
Jessica C. Böpple
ASAnas Skeik
Anas Skeik
MTMichael Tanner
Michael Tanner
TFThomas Ferbert
Thomas Ferbert
TBTim Niklas Bewersdorf
Tim Niklas Bewersdorf
SFSebastian Findeisen
Sebastian Findeisen
Background: Non-unions after fractures are known to be a devastating complication in trauma surgery and studies assessing long-term patient-reported, clinical, and radiological outcome measures are scarce. Most evidence-based research on non-unions and their long-term follow-up evaluate the first two post-operative years while excluding subsequent years and their impact on the overall outcome. This study aimed to evaluate the functional, clinical and radiological outcomes five years post-operative. Methods: In this prospective study, all patients treated operatively between June 2018 and December 2020 for non-unions including every site were systematically reviewed for inclusion and summoned for a follow-up after 5 years. The outcome was evaluated using the modified Lane-Sandhu-Score (LSS), the short-form 12 (SF-12), active range of motion (ROM) and visual analogue scale (VAS). Furthermore, data on complications was collected. For all analyses, a p -value < 0.05 was evaluated as significant. Results: A total of 45 patients were included in the study with a follow-up time of 63 months (IQR: 55; 66). The LSS median after five years was 4 (IQR: 4; 4) and of the VAS 0 (IQR: 0; 4). 95.6% of patients were satisfied with the therapy after five years. Regarding the SF-12, the median score for the mental component was 55.2 (IQR: 48.7; 58.8) and the physical component averaged at 44 ± 10.84. From the second to the fifth post-operative year, patients showed significant improvements in the LSS (Z = − 4.334, p < 0.0001). Additionally, improvements in VAS (3 [IQR: 0.5; 4.5] at one year vs. 0 [IQR: 0; 4.5] at five years; p = 0.008) as well as quality of life (SF12m median at 1 year 54.05 [IQR: 47.4; 57.05] vs. SF-12 m median at 5 years 56.2 [IQR: 50.7; 57.6, p = 0.08]; mean SF-12p at 1 year 42.77 ± 9.15 vs. mean SF-12p at 5 years 45.4 ± 9.91, p = 0.0468) were evident. 31% of the patients experienced an improvement in ROM compared to the last follow-up. Conclusion: This study demonstrates that even beyond the second postoperative year, significant progress in both radiological and clinical findings continues. As a result, patients with non-unions should continue to be examined in special out-patient clinics even after completing the first two years of follow-up.